Search Results - "Stefanski, Casey D"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response by Stefanski, Casey D, Prosperi, Jenifer R

    “…Resistance to chemotherapy occurs through mechanisms within the epithelial tumor cells or through interactions with components of the tumor microenvironment…”
    Get full text
    Journal Article
  2. 2

    APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells by Stefanski, Casey D., Keffler, Kaitlyn, McClintock, Stephanie, Milac, Lauren, Prosperi, Jenifer R.

    Published in Neoplasia (New York, N.Y.) (01-12-2019)
    “…Chemoresistance is one of the leading causes of cancer-related deaths in the United States. Triple negative breast cancer (TNBC), a subtype lacking the known…”
    Get full text
    Journal Article
  3. 3

    APC Loss Prevents Doxorubicin-Induced Cell Death by Increasing Drug Efflux and a Chemoresistant Cell Population in Breast Cancer by Stefanski, Casey D, Arnason, Anne, Maloney, Sara, Kotsen, Janna, Powers, Elizabeth, Zhang, Jian-Ting, Prosperi, Jenifer R

    “…Chemoresistance is a major health concern affecting cancer patients. Resistance is multifactorial, with one mechanism being the increased expression of ABC…”
    Get full text
    Journal Article
  4. 4

    Cftr Modulates Wnt/β-Catenin Signaling and Stem Cell Proliferation in Murine Intestine by Strubberg, Ashlee M, Liu, Jinghua, Walker, Nancy M, Stefanski, Casey D, MacLeod, R. John, Magness, Scott T, Clarke, Lane L

    “…Background & Aims Cystic fibrosis (CF) patients and CF mouse models have increased risk for gastrointestinal tumors. CF mice show augmented intestinal…”
    Get full text
    Journal Article
  5. 5

    SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death by Rosenbaum, Sheera R, Caksa, Signe, Stefanski, Casey D, Trachtenberg, Isabella V, Wilson, Haley P, Wilski, Nicole A, Ott, Connor A, Purwin, Timothy J, Haj, Jelan I, Pomante, Danielle, Kotas, Daniel, Chervoneva, Inna, Capparelli, Claudia, Aplin, Andrew E

    Published in Molecular cancer research (01-02-2024)
    “…The transcription factor, SOX10, plays an important role in the differentiation of neural crest precursors to the melanocytic lineage. Malignant transformation…”
    Get more information
    Journal Article
  6. 6

    Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy by Stefanski, Casey D, Prosperi, Jenifer R

    Published in Cancer drug resistance (01-01-2022)
    “…Triple negative breast cancer (TNBC) is marked by a lack of expression of the Estrogen Receptor, Progesterone Receptor, and human epidermal growth factor…”
    Get full text
    Journal Article
  7. 7

    Cellular chloride and bicarbonate retention alters intracellular pH regulation in Cftr KO crypt epithelium by Walker, Nancy M, Liu, Jinghua, Stein, Sydney R, Stefanski, Casey D, Strubberg, Ashlee M, Clarke, Lane L

    “…Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR), an anion channel providing a major pathway for Cl(-) and HCO3…”
    Get more information
    Journal Article
  8. 8

    APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation by VanKlompenberg, Monica K, Leyden, Emily, Arnason, Anne H, Zhang, Jian-Ting, Stefanski, Casey D, Prosperi, Jenifer R

    Published in Oncotarget (28-11-2017)
    “…Resistance to chemotherapy is one of the leading causes of death from breast cancer. We recently established that loss of (APC) in the Mouse Mammary Tumor…”
    Get full text
    Journal Article
  9. 9

    Abstract 1404: Loss of adenomatous polyposis coli induces DOX resistance through upregulation of ABC transporters by Stefanski, Casey D., Prosperi, Jenifer R., Milac, Lauren

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Chemoresistance is a leading cause of breast cancer related deaths. Therefore, understanding the molecular basis for chemoresistance is essential for novel…”
    Get full text
    Journal Article
  10. 10

    Abstract 4463: Loss of APC mediates doxorubicin resistance in breast cancer cells by Stefanski, Casey D., Keffler, Kaitlyn, McClintock, Stephanie, Prosperi, Jenifer R.

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Resistance to chemotherapy is one of the leading causes of breast cancer related deaths. Understanding the molecular basis for chemoresistance is essential for…”
    Get full text
    Journal Article
  11. 11

    Abstract 3246: APC loss prevents doxorubicin-induced cell death by effluxing drug and increasing a chemoresistant cell population by Stefanski, Casey D., Kotsen, Janna, Bernard, Amy, Prosperi, Jenifer

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Chemoresistance is a leading cause of breast cancer related deaths. Therefore, understanding the molecular basis for chemoresistance is essential for novel…”
    Get full text
    Journal Article
  12. 12

    Adenomatous Polyposis Coli Regulates ABC Transporters and DNA Repair Mechanisms to Cause Doxorubicin Resistance by Stefanski, Casey D

    Published 01-01-2022
    “…Chemoresistance is a leading cause of breast cancer related deaths. Therefore, understanding the molecular basis for chemoresistance is essential for novel…”
    Get full text
    Dissertation
  13. 13

    Abstract A023: Arachidonic acid metabolism promoting cross resistance in melanoma cells by Stefanski, Casey D., Erkes, Daniel A., Purwin, Timothy J., Mersky, Glenn L., Kitterman, Erica L., Mustafa, Manal, Haj, Jelan, Melissaratos, Diana, Aplin, Andrew E.

    Published in Cancer research (Chicago, Ill.) (17-11-2024)
    “…Melanoma patients initially respond well to first line immunotherapy. However, cross resistance to immunotherapy and BRAF/MEK inhibitor is a clinical challenge…”
    Get full text
    Journal Article
  14. 14

    Abstract 6942: Single cell resolution of intrapatient drug resistance mechanisms in metastatic melanoma by Wilson, Haley P., Mersky, Glenn L., Haj, Jelan I., Teh, Jessica, Cheng, Phil F., Caksa, Signe, Stefanski, Casey D., Chua, Vivian, Capparelli, Claudia, Levesque, Mitch P., Dummer, Reinhard, Purwin, Timothy J., Aplin, Andrew E.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Intrapatient heterogeneity among different metastatic sites contributes to immunotherapy (ICi) and targeted therapy resistance. Determining the evolution of…”
    Get full text
    Journal Article
  15. 15